ABOUT
The National Institutes of Health awarded an SBIR Phase II grant to Immuto Scientific, a drug discovery company based in Madison, Wisconsin, in 2022. Immuto said the grant would expand its research and development efforts.
PORTFOLIO · 1 COMPANY
ROUNDS · 1
National Institutes of Health took part in 1 round on listed companies. 1 has a public amount, totalling US$2.5Mn in round size (the investor's own cheque is not disclosed).
Amounts come from LightCastle Partners’ deal data, checked against public reports where they exist. Rounds with no confirmed amount show none. Round size, not the investor’s cheque.
See something wrong? Suggest a correction.